Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART)Razelle Kurzrock, Sandip Pravin Patel, Chris Ryan et al.|Journal for ImmunoTherapy of Cancer|2021Cited by 159
Deprivation of arginine by recombinant human arginase in prostate cancer cellsEddy C. Hsueh, Chung-Tsen Hsueh|Journal of Hematology & Oncology|2012Cited by 83